The groundbreaking treatment of the medication represents a major advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide993666.review-blogger.com/63643096/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment